Please ensure Javascript is enabled for purposes of website accessibility

Why IDEXX Laboratories, Inc. Jumped Higher Today

By Brian Orelli, PhD - Feb 2, 2017 at 3:49PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

It was a nice fourth quarter for the manufacturer of animal instruments and tests.

Veterinarian running a test on an IDEXX Laboratories machine

Image source: IDEXX Laboratories.

What happened

IDEXX Laboratories (IDXX 0.20%) was up almost 14% at 3:33 p.m. EST after announcing better-than-expected fourth-quarter earnings and raising its 2017 earnings guidance.

So what

Revenue during the quarter increased 11% year over year on the back of the company's tests for companion animals, which grew 13%. The number of instruments sold increased 15% year over year, while the growing installed base helped drive a 17% jump in sales of the consumables used in the instruments. Revenue from laboratory tests performed by IDEXX -- rather than in the veterinarian's office -- increased 12% year over year. The only downside to the segment was for IDEXX's rapid assay products, which only grew 6% year over year.

Tests for livestock, poultry, and dairy were down 1%, but fortunately this group makes up an ever-shrinking amount of IDEXX's revenue. The water-testing segment grew 1%, but it's even smaller.

The increased sales help IDEXX increase operating margins, allowing earnings to grow faster than revenue. In the fourth quarter, earnings per share increased 21% year over year to $0.58. For the year, that put earnings at $2.44 per share, substantially higher than the guidance of $2.35 to $2.39 per share announced at the end of the third quarter.

Now what

Management maintained its previously announced revenue guidance of $1.91 billion to $1.935 billion, but increased its guidance for earnings per share because of new accounting standards. The company is now looking for 2017 earnings per share in the $2.85 to $3.01 range, a 17% to 23% increase over last year's earnings.

Brian Orelli has no position in any stocks mentioned. The Motley Fool recommends Idexx Laboratories. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

IDEXX Laboratories, Inc. Stock Quote
IDEXX Laboratories, Inc.
IDXX
$374.75 (0.20%) $0.74

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
394%
 
S&P 500 Returns
127%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 08/19/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.